Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
Status:
Completed
Trial end date:
2018-07-17
Target enrollment:
Participant gender:
Summary
This placebo-controlled study will assess the safety and efficacy of a 90-day course of
treatment with ifetroban for portal hypertension in cirrhotic patients